Literature DB >> 15919378

IL-21 effects on human IgE production in response to IL-4 or IL-13.

Nancy Wood1, Karen Bourque, Debra D Donaldson, Mary Collins, Donata Vercelli, Samuel J Goldman, Marion T Kasaian.   

Abstract

In human atopic disease, IgE sensitizes the allergic response, while IgG4 is protective. Because IL-4 and IL-13 trigger switch recombination to both IgE and IgG4, additional agents must regulate the balance between these isotypes to influence susceptibility or tolerance to atopy. In this report, we define in vitro conditions leading to activation or inhibition of human IgE and IgG4 production by IL-21. IL-21 reduced IL-4-driven IgE synthesis by mitogen-stimulated human PBMC. IL-21 inhibition of human IgE production was not a direct effect on B cells, was not seen following B cell activation with IL-13, and was overcome by CD40 ligation. Neither IFN-gamma, IL-10, IL-12, CD40L expression, nor apoptosis was responsible for the inhibitory effect. In contrast, IL-21-stimulated secretion of IgG4 from PBMC. Our findings indicate that IL-21 may influence the production of both human IgE and IgG4, and thus contribute to the regulation of atopic reactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919378     DOI: 10.1016/j.cellimm.2005.01.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  23 in total

1.  BCR ligation antagonizes the IL-21 enhancement of anti-CD40/IL-4 plasma cell differentiation and IgE production found in low density human B cell cultures.

Authors:  Timothy H Caven; Jamie L Sturgill; Daniel H Conrad
Journal:  Cell Immunol       Date:  2007-09-21       Impact factor: 4.868

2.  Follicular helper T cells mediate IgE antibody response to airborne allergens.

Authors:  Takao Kobayashi; Koji Iijima; Alexander L Dent; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2016-05-18       Impact factor: 10.793

3.  Cervical lymph nodes, thyroiditis and ophthalmopathy: the pleomorphic face of an immunoglobulin g4-related disease.

Authors:  Christophe Ghys; Michel Depierreux; Elçin Ozalp; Brigitte Velkeniers
Journal:  Eur Thyroid J       Date:  2014-11-29

4.  Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy.

Authors:  David Vermijlen; Peter Ellis; Cordelia Langford; Anne Klein; Rosel Engel; Katharina Willimann; Hassan Jomaa; Adrian C Hayday; Matthias Eberl
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

Review 5.  IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.

Authors:  Maartje G Huijbers; Jaap J Plomp; Silvère M van der Maarel; Jan J Verschuuren
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

Review 6.  Pathophysiology of autoimmune pancreatitis.

Authors:  Raffaele Pezzilli; Nico Pagano
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

7.  A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation.

Authors:  Asif S Qaseem; Iesha Singh; Ansar A Pathan; Janice A Layhadi; Rebecca Parkin; Fedina Alexandra; Stephen R Durham; Uday Kishore; Mohamed H Shamji
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

Review 8.  Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy.

Authors:  Despina Michailidou; Daniella Muallem Schwartz; Tomas Mustelin; Grant C Hughes
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

9.  The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory.

Authors:  Jodi L Karnell; Rachel Ettinger
Journal:  Front Immunol       Date:  2012-01-24       Impact factor: 7.561

10.  The Hyper-IgE Syndromes: Lessons in Nature, From Bench to Bedside.

Authors:  Efren L Rael; Robert T Marshall; Jonathan J McClain
Journal:  World Allergy Organ J       Date:  2012-07       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.